FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967516433> ?p ?o ?g. }

• W2967516433 endingPage "338" @default.
• W2967516433 startingPage "338" @default.
• W2967516433 abstract "1433 Colorectal cancer (CRC) is the second leading cause of cancer death in the United States. Secondary bile acids (BA), in particular deoxycholic acid (DCA), promote colorectal adenomas (CRA) and CRC. Ursodeoxycholic acid (UDCA), the 7Β-epimer of chenodeoxycholic acid, has been shown to inhibit colorectal carcinogenesis in animal models and in individuals at increased risk of CRC. The precise mechanisms by which UDCA prevents CRC are unknown, but one potential mechanism is that UDCA alters the bile acid profile and reduces exposure of the colorectum to harmful effects of secondary BAs. We previously published results of a phase III trial of UDCA on CRA recurrence in 1285 subjects. The major findings were a non-significant 12% reduction in adenoma recurrence and a significant 39% reduction (p=0.03) in recurrence of adenomas with high-grade dysplasia (HGD). As part of this study we collected 72-hr fecal and plasma samples for BA analysis at baseline and 3 years of intervention on a subset of subjects, although in this analysis we focus only on the association of baseline BAs and risk of CRA recurrence in the placebo group. The median concentrations of UDCA and DCA in the aqueous fecal fraction were 0 μM/L (mean 39.7 ± SD 101.1) and 297.3 μM/L (mean 373.4 ±296.0) and in the plasma were 0.8 μM/L (mean 1.2 ± 1.5) and 0.9 μM/L (mean 1.0 ± 0.8). Spearman correlation coefficients for UDCA and DCA in aqueous fecal and plasma samples were 0.26 and 0.08, respectively. While previous small cross-sectional studies found unconjugated serum DCA to be associated with presence of CRAs, we found no association between unconjugated plasma DCA levels in the placebo group (N=78) and CRA recurrence at year 3 (p=0.09). In contrast, plasma UDCA levels were associated with reduced CRA recurrence –tertile of plasma UDCA and % adenoma recurrence : tertile 1 (0-0.5 μM/L), -76.9%, %; tertile 2 (0.5-1.2 μM/L), 65.4%, %; and tertile 3 (1.2-11.7 μM/L), 50.0% (p=0.04 for trend). The recurrence of adenomas with HGD was also significantly reduced with higher plasma UDCA (tertile 1—50.5%, tertile 2—26.9%, and tertile 3—20.0%, p=0.023 for trend). None of the baseline fecal BAs (N=365) from the placebo group were significantly associated with CRA recurrence or recurrence of CRAs with HGD. In conclusion, although previous studies have shown serum DCA to be higher in individuals with CRAs compared to controls, our study shows no association of baseline fecal or plasma DCA levels and risk of CRA recurrence. In contrast, baseline plasma but not fecal UDCA levels were associated with reduced risk of both CRA recurrence and recurrence of CRAs with HGD. These results complement those of the original phase III trial and further support a role of UDCA as a chempreventive agent for those at risk of CRC. Results also suggest that plasma UDCA may be a marker of reduced risk of CRA recurrence and recurrence of CRAs with HGD." @default.
• W2967516433 created "2019-08-22" @default.
• W2967516433 creator A5003605762 @default.
• W2967516433 creator A5012203996 @default.
• W2967516433 creator A5013275740 @default.
• W2967516433 creator A5040861518 @default.
• W2967516433 creator A5046781108 @default.
• W2967516433 creator A5059549925 @default.
• W2967516433 creator A5060238314 @default.
• W2967516433 creator A5060482328 @default.
• W2967516433 creator A5068318721 @default.
• W2967516433 creator A5075848871 @default.
• W2967516433 creator A5086541193 @default.
• W2967516433 creator A5089589253 @default.
• W2967516433 date "2006-04-15" @default.
• W2967516433 modified "2023-09-23" @default.
• W2967516433 title "Association of baseline fecal and plasma bile acids with colorectal adenoma recurrence and high-grade dysplasia in a phase III trial of colorectal adenoma recurrence" @default.
• W2967516433 hasPublicationYear "2006" @default.
• W2967516433 type Work @default.
• W2967516433 sameAs 2967516433 @default.
• W2967516433 citedByCount "0" @default.
• W2967516433 crossrefType "journal-article" @default.
• W2967516433 hasAuthorship W2967516433A5003605762 @default.
• W2967516433 hasAuthorship W2967516433A5012203996 @default.
• W2967516433 hasAuthorship W2967516433A5013275740 @default.
• W2967516433 hasAuthorship W2967516433A5040861518 @default.
• W2967516433 hasAuthorship W2967516433A5046781108 @default.
• W2967516433 hasAuthorship W2967516433A5059549925 @default.
• W2967516433 hasAuthorship W2967516433A5060238314 @default.
• W2967516433 hasAuthorship W2967516433A5060482328 @default.
• W2967516433 hasAuthorship W2967516433A5068318721 @default.
• W2967516433 hasAuthorship W2967516433A5075848871 @default.
• W2967516433 hasAuthorship W2967516433A5086541193 @default.
• W2967516433 hasAuthorship W2967516433A5089589253 @default.
• W2967516433 hasConcept C121608353 @default.
• W2967516433 hasConcept C126322002 @default.
• W2967516433 hasConcept C2775894508 @default.
• W2967516433 hasConcept C2776861080 @default.
• W2967516433 hasConcept C2777428134 @default.
• W2967516433 hasConcept C2778435480 @default.
• W2967516433 hasConcept C2779399885 @default.
• W2967516433 hasConcept C2780749602 @default.
• W2967516433 hasConcept C2780965833 @default.
• W2967516433 hasConcept C526805850 @default.
• W2967516433 hasConcept C71924100 @default.
• W2967516433 hasConcept C90924648 @default.
• W2967516433 hasConceptScore W2967516433C121608353 @default.
• W2967516433 hasConceptScore W2967516433C126322002 @default.
• W2967516433 hasConceptScore W2967516433C2775894508 @default.
• W2967516433 hasConceptScore W2967516433C2776861080 @default.
• W2967516433 hasConceptScore W2967516433C2777428134 @default.
• W2967516433 hasConceptScore W2967516433C2778435480 @default.
• W2967516433 hasConceptScore W2967516433C2779399885 @default.
• W2967516433 hasConceptScore W2967516433C2780749602 @default.
• W2967516433 hasConceptScore W2967516433C2780965833 @default.
• W2967516433 hasConceptScore W2967516433C526805850 @default.
• W2967516433 hasConceptScore W2967516433C71924100 @default.
• W2967516433 hasConceptScore W2967516433C90924648 @default.
• W2967516433 hasLocation W29675164331 @default.
• W2967516433 hasOpenAccess W2967516433 @default.
• W2967516433 hasPrimaryLocation W29675164331 @default.
• W2967516433 hasRelatedWork W1522898823 @default.
• W2967516433 hasRelatedWork W1571975801 @default.
• W2967516433 hasRelatedWork W2030342055 @default.
• W2967516433 hasRelatedWork W2042986482 @default.
• W2967516433 hasRelatedWork W2052926537 @default.
• W2967516433 hasRelatedWork W2152382427 @default.
• W2967516433 hasRelatedWork W2272805178 @default.
• W2967516433 hasRelatedWork W2413827290 @default.
• W2967516433 hasRelatedWork W2592992458 @default.
• W2967516433 hasRelatedWork W2594789914 @default.
• W2967516433 hasRelatedWork W2972902118 @default.
• W2967516433 hasRelatedWork W2988607749 @default.
• W2967516433 hasRelatedWork W3032250218 @default.
• W2967516433 hasRelatedWork W3091984586 @default.
• W2967516433 hasRelatedWork W3109815715 @default.
• W2967516433 hasRelatedWork W3112715707 @default.
• W2967516433 hasRelatedWork W3186873605 @default.
• W2967516433 hasRelatedWork W3195038440 @default.
• W2967516433 hasRelatedWork W32611715 @default.
• W2967516433 hasRelatedWork W3149476270 @default.
• W2967516433 hasVolume "66" @default.
• W2967516433 isParatext "false" @default.
• W2967516433 isRetracted "false" @default.
• W2967516433 magId "2967516433" @default.
• W2967516433 workType "article" @default.